Delivery Order SPE2DB25D9236-SPE2DB25FPQQV

Award Date 4/29/25
Potential Completion Date 5/20/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,672.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,567,937,905 units of Botox 200 unit vials, with a completion date of May 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order valued at $22,034.40 and has an ultimate completion date of May 13, 2025. The contract is for the delivery of 4,568,037,211 units of Botox 200 unit vials. This contract is not associated with a set-aside and is part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award, valued at $32,342.50, is for the delivery of 4,567,937,903 units of Botox 200 unit vials. The contract is a firm fixed-price delivery order with a completion date of May 5, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,017.20, is for the delivery of Botox 200 unit vials. The contract is a firm fixed-price delivery order, with a period of performance ending on May 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA, valued...
This federal contract award, valued at $11,017.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4,568,012,839 units of Botox 200 unit vials, with a period of performance through May 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026....
This federal contract award, valued at $4,614.80, was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical supplier based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 100 unit vials, with an ultimate completion date of April 22, 2024. This award appears to be a delivery order issued under a larger indefinite delivery vehicle (IDV) contract, contract # SPE2DB, that DMS Pharmaceutical...
This is a single federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of BOTOX 100 unit vials, with a total ceiling value of $1,384.44. The contract has a performance period through May 7, 2024 and was awarded on April 16, 2024. This contract award is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,771.50, is for the delivery of 4,568,012,828 units of Botox 200 unit vials. The contract is a firm fixed-price delivery order with a period of performance ending on May 13, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $13,771.50 firm fixed-price delivery order is for the supply of 4,567,950 units of Botox 200-unit vials. The contract has an ultimate completion date of May 5, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,768.88 contract is for the delivery of BOTOX 100 unit vials and has a completion date of September 5, 2024. The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which enables the agency to place orders for a comprehensive...
  • SPE2DB25D9236
    Indefinite Delivery Contract
  • SPE2DB25D9236-SPE2DB25FPQQV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award, valued at $3,672.40, is for the delivery of 4,568,099,651 units of Botox 200 unit vials. The contract is a firm fixed-price delivery order with a completion date of May 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 7/29/25, 9:48 AM